0
Observation |

Successful Treatment of Rosai-Dorfman Disease With Low-Dose Oral Thalidomide

Xiaodong Li, MD, PhD1,2; Yuxiao Hong, MD2; Qian An, MD2; John Chen, MD3; Huachen Wei, MD, PhD4; Hong-Duo Chen, MD2; Xing-Hua Gao, MD, PhD2
[+] Author Affiliations
1Fengtian Hospital Affiliated with Shenyang Medical College, Shenyang, China
2Department of Dermatology, No. 1 Hospital of China Medical University, Shenyang
3Sheftel Associates Dermatology, Tucson, Arizona
4Department of Dermatology, Dermatology Research Laboratories, Mount Sinai Medical Center, New York, New York
JAMA Dermatol. 2013;149(8):992-993. doi:10.1001/jamadermatol.2013.4399.
Text Size: A A A
Published online

Extract

Rosai–Dorfman disease (RDD) is a rare idiopathic histiocytic proliferative disorder.1 The skin is the most frequently involved extranodal organ. Nevertheless, primary cutaneous manifestation of RDD (CRDD) without systemic involvement is rare.2 We present herein a case of CRDD showing excellent remission after low-dose oral thalidomide therapy.

Article InformationCorresponding Authors: Xing-Hua Gao, MD, PhD, and Hong-Duo Chen, MD, Department of Dermatology, No. 1 Hospital of China Medical University, 155 N Nanjing St, Shenyang 110001, People’s Republic of China (gaobarry@hotmail.com).

Published Online: June 19, 2013. doi:10.1001/jamadermatol.2013.4399.

Conflict of Interest Disclosures: None reported.

Funding/Support: This work was supported in part by the Program for Innovative Research Team in Universities, Liaoning Province (LT2012012), National Natural Science Foundation of China (30972659).

Role of the Sponsors: The sponsors had no role in the design and conduct of the study; collection, management, analysis, and interpretation of the data; and preparation, review, or approval of the manuscript; and decision to submit the manuscript for publication.

Additional Contributions: Written informed consent was obtained from the patient for submission and publication of this case report and accompanying images.

Figures in this Article

Sign In to Access Full Content

Don't have Access?

Register and get free email Table of Contents alerts, saved searches, PowerPoint downloads, CME quizzes, and more

Subscribe for full-text access to content from 1998 forward and a host of useful features

Activate your current subscription (AMA members and current subscribers)

Purchase Online Access to this article for 24 hours

First Page Preview

View Large
/>
First page PDF preview

Figures

Place holder to copy figure label and caption
Figure 1.
Clinical Images

A, Erythematous plaques with reddish-yellow nodules on his face. B, After 8 months of thalidomide treatment, the nodules are nearly resolved, and most of erythematous plaques are lightened or even cleared.

Graphic Jump Location

Tables

References

Correspondence

CME
Meets CME requirements for:
Browse CME for all U.S. States
Accreditation Information
The American Medical Association is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. The AMA designates this journal-based CME activity for a maximum of 1 AMA PRA Category 1 CreditTM per course. Physicians should claim only the credit commensurate with the extent of their participation in the activity. Physicians who complete the CME course and score at least 80% correct on the quiz are eligible for AMA PRA Category 1 CreditTM.
Note: You must get at least of the answers correct to pass this quiz.
You have not filled in all the answers to complete this quiz
The following questions were not answered:
Sorry, you have unsuccessfully completed this CME quiz with a score of
The following questions were not answered correctly:
Commitment to Change (optional):
Indicate what change(s) you will implement in your practice, if any, based on this CME course.
Your quiz results:
The filled radio buttons indicate your responses. The preferred responses are highlighted
For CME Course: A Proposed Model for Initial Assessment and Management of Acute Heart Failure Syndromes
Indicate what changes(s) you will implement in your practice, if any, based on this CME course.
NOTE:
Citing articles are presented as examples only. In non-demo SCM6 implementation, integration with CrossRef’s "Cited By" API will populate this tab (http://www.crossref.org/citedby.html).
Submit a Comment

Multimedia

Some tools below are only available to our subscribers or users with an online account.

Sign In to Access Full Content

Related Content

Customize your page view by dragging & repositioning the boxes below.

Articles Related By Topic
Related Topics
PubMed Articles
Jobs
brightcove.createExperiences();